Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.20.2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jul. 02, 2020
Jul. 02, 2020
Jan. 14, 2020
Jan. 14, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Net proceeds from public offering of common stock     $ 50,000,000.0     $ 46,639,210 $ 30,103,306  
Series B Convertible Preferred stock shares designated           8,000   8,000
Series B Convertible Preferred stock, shares outstanding           4,552   4,577
Series B Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Dividend payable description           Subject to certain ownership limitations, holders of the Series B Preferred Stock received or are entitled to receive dividends payable in the Company’s common stock as follows: (i) a number of shares of common stock equal to 10% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on June 19, 2019, (ii) a number of shares of common stock equal to 15% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on June 19, 2020 and (iii) a number of shares of common stock equal to 20% of the shares of common stock underlying the Series B Preferred Stock then held by such holder on June 19, 2021    
Stock dividend, shares           1,365,600 946,000  
Merger Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Net proceeds from public offering of common stock     $ 46,700,000          
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of underwritten public offering of common stock     32,300,000     32,260,000    
Purchase price     $ 1.55 $ 1.55        
Stock dividend, shares         3,522,860 1,365,600 4,468,860  
Common Stock [Member] | Maximum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Options to purchase an additional shares of common stock     4,800,000          
Warrant [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of warrant to purchase of common stock           1,327,810    
Warrant [Member] | Maximum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Class of warrant or right, exercise price of warrants or rights           $ 0.75    
Warrant [Member] | Minimum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Class of warrant or right, exercise price of warrants or rights           $ 0.50    
Underwritten Public Offering [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Net proceeds from public offering of common stock       $ 46,700,000        
Market Sales Agreement [Member] | Lab Equipment [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Net proceeds from public offering of common stock   $ 50,000,000            
Sales Agreement [Member] | Underwritten Public Offering [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Sale of stock percentage 3.00%